Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management
DOI:
https://doi.org/10.5489/cuaj.12Abstract
Introduction: We assess physicians’ ability to accurately predictlife expectancies. In prostate cancer this prediction is especiallyimportant as it affects screening decisions. No previous studieshave examined accuracy in the context of real cases and concreteend points.
Methods: Seven clinical scenarios were summarized from chartsof deceased patients. We recruited 100 medical professionals toreview these scenarios and estimate each patient’s life expectancy.Responses were analyzed with respect to the patients’ actual survivalend points, then stratified based on the demographic informationprovided.
Results: Respondent factors, such as sex, level of training, locationof work or specialty, made no significant difference on predictionaccuracy. Furthermore, respondents were typically pessimistic intheir estimations with a negative linear trend between estimated lifeexpectancy and actual survival. Overall, respondents were within 1year of actual life expectancy only 15.9% of the time; on average,respondents were 67.4% inaccurate in relation to actual survival. Ifframed in terms of correctly identifying which patients would livemore than or less than 10 years (dichotomous accuracy), physicianswere correct 68.3% of the time.
Conclusions: Physicians do poorly at predicting life expectancyand tend to underestimate how long patients have left to live.This overall inaccuracy raises the question of whether physiciansshould refine screening and treatment criteria, find a better proxyor dispose of the criteria altogether.
Downloads
References
Statistics Canada. Canadian Vital Statistics, Births and Deaths Databases, Demography Division, CANSIM
Table 102-0511. http://www5.statcan.gc.ca/cansim (Accessed September 11, 2012).
Heron M, Hoyert DL, Murphy SL, et al. Deaths: final data for 2006. Natl Vital Stat Rep 2009;57:1-134.
Ellison LF, De P, Mery LS, et al. Canadian cancer statistics at a glance: cancer in children. CMAJ
;180:422-4. http://dx.doi.org/10.1503/cmaj.081155
American Urological Association: Prostate-Specific Antigen Best Practice Statement: 2009. http://www.
auanet.org/content/media/psa09.pdf (Accessed September 11, 2012).
Greene KL, Albertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update.
J Urol 2009;182:2232-41. http://dx.doi.org/10.1016/j.juro.2009.07.093
Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate
cancer: update 2010. CA Cancer J Clin 2010;60:70-98. http://dx.doi.org/10.3322/caac.20066
Mistry S, Mayer W, Khavari R et al: Who’s Too Old To Screen? Prostate Cancer in Elderly Men. Can Urol
Assoc J 2009;3:205-10.
Altman DG: Practical statistics for medical research. London: Chapman and Hall; 1991.
Pearce A, Newcomb C, Husain S. Recommendations by Canadian urologists and radiation oncologists for
the treatment of clinically localized prostate cancer. Can Urol Assoc J 2008;2:197-203.
U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force
recommendation statement. Ann Intern Med 2008;149:185-91.
U.S. Preventive Services Task Force. Screening for Prostate Cancer: U.S. Preventive Services Task Force
Recommendation Statement draft 2011; 2012.
Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate-cancer screening
trial. N Engl J Med 2009;360:1310-9. http://dx.doi.org/10.1056/NEJMoa0810696
Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8. http://dx.doi.org/10.1056/NEJMoa0810084
Kirwan JR, Chaput de Saintonge DM, Joyce CR, et al. Clinical judgment in rheumatoid arthritis. I. Rheumatologists’ opinions and the development of ‘paper patients’. Ann Rheum Dis 1983;42:644-7. http://dx.doi.org/10.1136/ard.42.6.644
Christakis NA, Lamont EB. Extent and determinants of error in physicians’ prognoses in terminally ill patients: prospective cohort study. West J Med 2000;172:310-3. http://dx.doi.org/10.1136/
ewjm.172.5.310
Wilson JR, Clarke MG, Ewings P, et al. The assessment of patient life-expectancy: how accurate are urologists and oncologists? BJU Int 2005;95:794-8. http://dx.doi.org/10.1111/j.1464-410X.2005.05403.x
Chow E, Davis L, Panzarella T, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys 2005;61:870-3. http://dx.doi.org/10.1016/j.ijrobp.2004.07.697
Walz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 2007;100:1254-8. http://dx.doi.
org/10.1111/j.1464-410X.2007.07130.x
Albertsen PC, Fryback DG, Storer BE, et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996;156:127-32. http://dx.doi.org/10.1016/S0022-5347(01)65964-0
Krahn MD, Bremner KE, Asaria J, et al. The ten-year rule revisited: accuracy of clinicians’ estimates of life expectancy in patients with localized prostate cancer. Urology 2002;60:258-63. http://dx.doi.org/10.1016/S0090-4295(02)01712-0
Koch MO, Miller DA, Butler R, et al. Are we selecting the right patients for treatment of localized prostate
cancer? Results of an actuarial analysis. Urology 1998;51:197-202. http://dx.doi.org/10.1016/S0090-4295(97)00622-5
Henderson R, Keiding N. Individual survival time prediction using statistical models. J Med Ethics 2005;31:703-6. http://dx.doi.org/10.1136/jme.2005.012427
Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006;175:99-103. http://dx.doi.org/10.1016/S0022-5347(05)00018-2
The World Health Organization. Prostate Cancer Screening 2009; 2009.
Izawa JI, Klotz L, Siemens DR, et al. Prostate Cancer Screening: Canadian Guidelines 2011. Can Urol Assoc J 2011;5:235-40. http://dx.doi.org/10.5489/cuaj.11134
Canadian Cancer Society. Understanding the Pros and Cons of Prostate Cancer Testing 2009; 2009.
Feightner JW. The early detection and treatment of prostate cancer: the perspective of the Canadian Task
Force on the Periodic Health Examination. J Urol 1994;152:1682-4.
National Cancer Institute. Prostate Cancer Screening 2009; 2009.
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.